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Abstract Paroxysmal dystonic choreoathetosis (PDC) is
a rare neurological disorder characterized by episodes of
involuntary movement, involving the extremities and
face, which may occur spontaneously or be precipitated
by caffeine, alcohol, anxiety, and fatigue. PDC is trans-
mitted as an autosomal dominant trait with incomplete
penetrance. A gene implicated in this paroxysmal disor-
der has been mapped to a 10–15 cM region on chromo-
some 2q31–36 in two families. We describe a third fam-
ily with PDC. Two-point linkage analyses with markers
linked to the candidate PDC locus were performed. A
maximum two-point LOD score of 4.20 at a recombina-
tion fraction of zero was obtained for marker D2S120,
confirming linkage to the distal portion of chromosome
2q. The anion exchanger gene, SLC2C, maps to this re-
gion, but the family was poorly informative for polymor-
phic markers within and flanking this candidate gene.
Haplotype analysis revealed a critical recombination
event that confines the PDC gene to a 5-cM region
bounded by the markers D2S164 and D2S377. We com-
pared the haplotype in our family with that in another
chromosome 2-linked PDC family, but did not detect a
region of shared genotypes. However, identifying a third
family whose disease maps to the same region and nar-
rowing the critical region will facilitate identification of
the 2q-linked PDC gene.
Introduction
Movement disorders comprise a diverse group of syn-
dromes that can be sporadic or familial, congenital or ac-
quired. They are classified by distinct types of movement,
precipitating factors, age of onset and duration of symp-
toms (Richards and Barnett 1968; Lance 1977; Goode-
nough et al. 1978; Demirkiran and Jankovic 1995). Parox-
ysmal dystonic choreoathetosis (PDC, MIM11880) is
characterized by episodes of dystonic posturing and
choreoathetotic movement. Attacks, which usually begin
in childhood or young adulthood, typically start with a
tugging sensation, usually in one hand or one foot, fol-
lowed by dystonic spasms of the face and limbs, which
may progress to involve the entire body. The facial dysto-
nia may cause slurred speech. Attacks can be precipitated
by caffeine, alcohol, chocolate, emotional stress, anxiety
or fatigue, but may also occur spontaneously. Physical ex-
ertion does not bring on attacks. Episodes may last for
minutes to hours. Clonazepam has been helpful in con-
trolling the spasmodic attacks, whereas other barbiturates
and phenytoin are less effective. Its prolonged duration,
precipitating factors, and the ineffectiveness of certain
treatments distinguish PDC from similar syndromes, such
as paroxysmal kinesiogenic choreoathetosis, which are
characterized by shorter lasting, movement-induced symp-
toms and often respond to phenytoin (Kertesz 1967; De-
mirkiran and Jankovic 1995).
Molecular linkage analyses have demonstrated hetero-
geneity in the paroxysmal disorders associated with dys-
tonia and choreoathetosis. Recently, a PDC locus has
been mapped to the distal region of chromosome 2q in
two unrelated families with choreoathetosis and dystonia
(Fink et al. 1996; Fouad et al. 1996), whereas a locus for
a syndrome associated with choreoathetosis and spastic-
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ity has been mapped to chromosome 1p (Auberger et al.
1996).
Abnormalities in gated calcium, sodium, chloride, and
potassium ion channels have been found to be responsible
for several familial paroxysmal neurologic diseases (e.g.,
Cannon et al. 1991; McClatchey et al. 1992; Browne et al.
1994; Jurkat-Rott et al. 1994; Ptacek et al. 1994; Hudson
et al. 1995; Mailander et al. 1996). The episodic nature of
PDC suggests that it may have as its basis mutations in an
ion channel gene. We report linkage studies and prelimi-




We evaluated a three-generation North American family of Ger-
man descent segregating an episodic movement disorder charac-
terized by staring, muscle stiffness, and choreoathetotic move-
ment. Part of the pedigree of family ED01 is shown in Fig.1. On-
set was in childhood except in individual IV-9, whose first attack
occurred in her late twenties. Episodes progressed from a tighten-
ing sensation of the extremities on one or both sides to flexion,
contraction and twisting of the arms and legs. Involvement of the
muscles of the face resulted in slurred or unintelligible speech and
dysphagia. The episodes typically lasted from several minutes to
several hours and varied in frequency from once a day to once a
month. Attacks generally were precipitated by caffeinated drinks
(especially coffee), alcohol, chocolate, cocoa, fatigue, hunger and
anxiety, although during a recent evaluation of individual III-6
consumption of strong black tea and a large chocolate bar did not
induce an episode. Several affected family members reported that
meprobamate, TUMS and vinegar were effective preventive
agents. Exercise, muscle stretching or rubbing the extremities
were also reportedly of some benefit. Between episodes, physical
examinations were entirely normal, with no neurological abnor-
malities detected. The movement disorder in this family appears
to be transmitted as an autosomal dominant trait with incomplete
penetrance. One obligate heterozygote, IV-11, is completely
asymptomatic at age 36; other unaffected obligate heterozygotes
have previously been reported (Fink et al. 1996; Fouad et al.
1996).
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Fig.1 Partial pedigree of family ED01 showing individuals af-
fected by paroxysmal dystonic choreoathetosis as black symbols.
The order of markers and distance in centimorgans given in the in-
set are according to GDB Linkage Map 1212462 and 1996 Chro-
mosome 2 Workshop Integrated Consensus Map 4225469. The pu-
tative disease haplotypes is shown in white letters on a black chro-
mosome segment. Inferred haplotypes are enclosed in brackets and
have been constructed to minimize the number of recombination
events. The location of SLC2C relative to the other markers is not
known. Genotypes for the SLC2C-linked polymorphic marker
SLC4A3 are arbitrarily shown above the others
Genotyping
Under protocols approved by the Institutional Review Board of the
University of Washington, blood samples from 16 family members
were collected into EDTA-containing tubes and genomic DNA
was isolated from leukocytes or cell lines according to the salt-
chloroform extraction method described by Mullenbach et al.
(1989). DNA was PCR-amplified in a MJ Research PTC-100 pro-
grammable thermal controller as previously described (Raskind et
al. 1995). Genotypes were evaluated for markers linked to PDC
(D2S128, D2S164, D2S173, D2S295, D2S163, D2S120, D2S377,
D2S126, D2S313, D2S130, D2S133, D2S159), idiopathic torsion
dystonia (GSN, D9S282, D9S60, ASS), hereditary progressive
dystonia/dopa-responsive dystonia (D14S52, D14S66, D14S566,
HSPA2), episodic ataxia and a cluster of potassium channel genes
(D12S372, D12S99, D12S93) (Browne et al. 1994; Litt et al.
1994), as well as for a short tandem repeat (STRP) polymorphism
(SLC4A3) identified within an SLC2C-containing cosmid (Su et
al. 1994). SLC2C is an ion exchanger gene on chromosome 2q36.
MapPair oligonucleotide primers were obtained from Research
Genetics and one primer of each pair was end-labeled with [γ32]P
by a T4 kinase reaction. In some cases, multiplex PCR reactions
with two to three primer sets were done when the range of allele
sizes allowed clear separation of products. Allele sizes on the auto-
radiographs were standardized by comparison to DNAs from
CEPH family 1331 (Dausset et al., 1990).
Linkage analysis
Two-point linkage analyses were performed with the MLINK and
ILINK subroutines of the LINKAGE program, version 5.1 (Cot-
tingham et al. 1993; Lathrop et al. 1984, 1986; Lathrop and
Lalouel 1984; Schaffer et al. 1994). Autosomal dominant inheri-
tance with a disease allele frequency or 0.0001 was assumed for
the PDC locus and analyses were done for penetrance values of
0.90 and 0.80. Allele sizes and frequencies for polymorphic loci
were obtained from the Genome Data Base (GDB). Order and dis-
tances between the loci were obtained from GDB Généthon Link-
age Map 1212462, 1996 Chromosome 2 Workshop Integrated
Consensus Map 4225469 and Chromosome 2 Cytogenetic Map
1012596. The previously unreported alleles of D2S128 (allele 3 is
154 bp), D2S164 (alleles 2 and 6 are 275 bp and 295 bp, respec-
tively), D2S159 (alleles 1, 2, 4 and 8 are 153 bp, 163 kb, 167 bp
and 179 bp, respectively) observed were each arbitrarily assigned
a frequency of 0.01.
Results
Exclusion analysis
We analyzed polymorphic loci flanking genes responsible
for the neurological disorders, idiopathic torsion dystonia
(ITD, Bressman et al. 1994; Ozelius et al. 1989, 1992),
episodic ataxia (EA, KCNA1; Browne et al. 1994) and
hereditary progressive dystonia/dopa-responsive dystonia
(HPD/DRD; Ichinose et al. 1994; Tanaka et al. 1995), as
possible candidate genes for the disorder in family ED01.
Haplotypes were constructed by hand. For each candidate
gene, there was no association between a specific haplo-
type and the phenotype of PDC in family ED01. There-
fore, these genes, as well as the other potassium (KCNA5,
KCNA6) and calcium (CACNL1A1) ion channel genes
linked to EA (Litt et al. 1994), are not etiologic in PDC
(data not shown).
Linkage to 2q31–36
Linkage was then evaluated to 12 microsatellite markers
localized to 2q31–36, a region recently implicated in two
families with PDC whose phenotypes resembled that seen
in ED01 (Fink et al. 1996; Fouad et al. 1996). We ob-
served one confirmed instance of incomplete penetrance
in family ED01 (individual IV-11), thus leading us to a
rough estimate of 8/9 or ≈ 90% for penetrance. Table 1
shows the two-point LOD scores derived under the as-
sumption of autosomal dominance, disease allele fre-
quency of 0.0001 and the estimated penetrance of 90%.
However, the small number of subjects analyzed does not
allow us to state reliably the actual penetrance of this dis-
order. Thus, we also calculated the lod scores under a
model in which the penetrance was only 80%. With pene-
trance set at 90% a maximum pairwise lod score of 4.19 at
θ = 0.001 was obtained for the marker D2S120. As ex-
pected, lower lod scores were obtained when the pene-
trance was set at 80%, but a significant maximum lod
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Table 1 Two-point linkage
analysis for markers on chro-
mosome 2q
Marker Lod score (Z) at recombination fraction (θ) of Zmax θmax
0.001 0.01 0.05 0.10 0.20 0.30 0.40
D2S128 2.06 2.05 1.99 1.86 1.50 1.02 0.45 2.06 0.001
D2S164 3.54 3.51 3.31 3.04 2.39 1.65 0.84 3.55 0.001
D2S173 2.03 1.98 1.77 1.50 0.96 0.47 0.12 2.03 0.001
D2S295 3.84 3.78 3.49 3.11 2.31 1.47 0.63 3.85 0.001
D2S163 2.27 2.23 2.05 1.83 1.37 0.89 0.37 2.27 0.001
D2S120 4.19 4.12 3.82 3.43 2.59 1.70 0.78 4.20 0.001
D2S377 –0.12 0.82 1.33 1.39 1.17 0.79 0.32 1.39 0.088
D2S126 0.48 1.42 1.88 1.87 1.54 1.04 0.46 1.90 0.071
D2S313 –2.34 –1.32 –0.52 –0.18 0.05 0.06 0.00 0.344 0.5
D2S130 –1.58 –0.61 –0.01 0.18 0.26 0.22 0.13 0.262 0.196
D2S133 0.04 0.04 0.05 0.05 0.04 0.02 0.00 0.50 0.069
D2S159 –1.77 –0.75 0.02 0.33 0.50 0.41 0.20 0.50 0.202
SLC4A3 1.68 1.65 1.50 1.31 0.94 0.58 0.26 1.69 0.001
score of 3.96 was still achieved for D2S120 at θ = 0.001.
The fact that the maximum lod score was higher at a pen-
etrance of 90% than at 80% supports the validity of the
higher penetrance in EDS (Clerget-Darpoux et al. 1986;
Elston 1989; Greenberg 1989).
To narrow the critical region containing the PDC gene,
haplotypes were evaluated for informative recombination
events. Individuals IV-1 and IV-2 share the portion of the
haplotype including and proximal to marker D2S120 with
all other affected members and obligate heterozygotes in
the family. A recombination event must have occurred be-
tween PDC and D2S377 in one of the ancestors, II-1, II-4
or III-1.
Linkage to candidate gene SLC2C
Individual III-6 was homozygous for the STRP marker
tightly physically linked to SLC2C (Su et al. 1994).
Therefore, linkage (Table 1) and haplotype (Fig.1) analy-
ses were not maximally informative.
Discussion
Given the clinical similarities between disease in our fam-
ily and PDC, we evaluated linkage to the recently re-
ported PDC locus on chromosome 2q31–36 (Fink et al.
1996; Fouad et al. 1996). We also considered as candidate
loci the map positions for ITD (ITD1) on chromosome
9q34 (Ozelius et al. 1992) and HPD (GTP cyclohydrolase
I) on chromosome 14q2.1–q22.2 (Ichinose et al. 1994;
Tanaka et al. 1995). The paroxysmal nature of the attacks
experienced by affected individuals in family ED01 sug-
gests that an abnormal ion channel gene might be respon-
sible. Mutations in sodium, chloride, potassium and cal-
cium ion channel genes have been found to cause other
familial neuromuscular diseases characterized by the
episodic occurrence of symptoms (e.g., Cannon et al.
1991; Browne et al. 1994; Ptacek et al. 1994; Hudson et
al. 1995; Mailander et al. 1996). Therefore, we analyzed
linkage to the cluster of potassium channel genes
KCNA5, KCNA6, KCNA1 and the calcium channel gene
CACNL1A1 at chromosome 12p13 (Litt et al. 1994)
mapped to the region containing the locus for EA. An-
other calcium channel gene, CACNL1A5, maps to chro-
mosome 9q32–34 near ITD1.
The penetrance of PDC appears to be high. In family
ED01, there are eight clinically affected individuals and
one unexpressing obligate heterozygote. We obtained sig-
nificant evidence in favor of linkage of disease in family
ED01 to chromosome 2q31–36 even under a conservative
penetrance estimate of 80%. No evidence for linkage to
the other regions was found. Combined haplotype infor-
mation from two prior studies localized PDC to the 6-cM
region bounded proximally by D2S164 (Fink et al. 1996)
and distally by D2S126 (Fouad et al. 1996). The recombi-
nation event in our family narrows the critical region to
the 5-cM interval between D2S164 and D2S377.
The anion exchanger gene SLC2C maps to chromo-
some 2q between D2S128 and D2S126, but its position
relative to the other markers employed in this study is not
known precisely (Su et al. 1994). Unfortunately, the geno-
types of individuals in ED01 for a polymorphism identi-
fied within a SLC2C-containing cosmid were not fully in-
formative and did not allow localization of this candidate
gene within the other 12 markers tested on chromosome
2q or exclusion from the critical region for PDC. Addi-
tional studies of SLC2C in affected members of this fam-
ily are underway.
PDC is a very rare member of the syndromes associ-
ated with choreoathetotic and dystonic movements. Very
few families with PDC have been reported since its first
description by Mount and Reback in 1940. Linkage stud-
ies in three families with episodic choreoathetosis have
demonstrated locus heterogeneity. The disease gene in
one family whose illness is characterized by spasticity
that persists between attacks in some affected individuals
was mapped to chromosome 1p (Auberger et al. 1996).
There are striking clinical similarities among ED01 and
the two families in which affected individuals showed
dystonic posturing, but not spasticity, and who were neu-
rologically normal between episodes (Fink et al. 1996;
Fouad et al. 1996). The disease locus in all three of these
families maps to chromosome 2q; there is no evidence for
genetic heterogeneity within PDC not associated with
spasticity. To look for evidence of a common mutational
origin in this rare disorder, we compared the haplotypes
in ED01 and the kindred described by Fink et al. (1996).
A shared region of genotypes was not detected for mark-
ers in or near the critical region on chromosome
2q31–36.
Several schemes to classify the dystonic syndromes
into subtypes have been proposed, based on the nature of
the provocative stimuli (kinesiogenic versus nonkinesio-
genic), age of onset of symptoms, duration of symptoms
and response to therapy (Lance 1977; Goodenough et al.
1978; Fahn 1994; Demirkiran et al. 1995). Additional
mapping studies and the eventual cloning of the causative
gene(s) will determine whether this clinical scheme is bi-
ologically meaningful. Identification of the gene involved
in PDC will advance our understanding of the normal hu-
man motor system and suggest possible treatment strate-
gies for the disease.
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